Status:
UNKNOWN
Ablation of Supraventricular Arrhythmias With As Low As Reasonably Achievable X-Ray Exposure
Lead Sponsor:
Mohamed Bin Khalifa Bin Sulman Al Khalifa Cardiac Centre
Conditions:
Tachycardia, Supraventricular
Eligibility:
All Genders
18+ years
Brief Summary
Observational study is to demonstrate a clinically significant reduction of ionizing radiation exposure during transcatheter ablation of supraventricular tachycardias using the EnSite precision mappin...
Eligibility Criteria
Inclusion
- Male or female patients ≥ 18 years of age
- Patient indicated for supraventricular arrhythmias ablation according to the current guidelines
- Patient is willing to provide written informed consent.
Exclusion
- Patient is pregnant.
- Contraindications to ionizing radiation exposure
- Patient's life expectancy is less than 1 year
- Associated complex congenital heart disease
- Cardiac implantable electric devices
- Known pathological venous access to the heart
Key Trial Info
Start Date :
January 20 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 1 2023
Estimated Enrollment :
700 Patients enrolled
Trial Details
Trial ID
NCT04716270
Start Date
January 20 2021
End Date
March 1 2023
Last Update
September 6 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mohamed Bin Khalifa Cardiac Center
Riffa, Bahrain